Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2940 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Medtronic acquires Restore Medical

Under the terms of the agreement announced earlier, Restore shareholders will receive $1.60 per share in cash for each share of Restore common stock they own. The total

OptiMedica names new CFO

Prior to joining OptiMedica, Mr Murray spent more than 20 years at Guidant and its predecessor, Advanced Cardiovascular Systems. Mr Murray brings to OptiMedica more than 25 years

Thermo Fisher Scientific acquires Affinity BioReagents

Affinity BioReagents provides recombinant proteins and custom antibody-production services. The company had annual revenues of approximately $6 million in 2007, and will be integrated into Thermo Fisher’s analytical

Teva to acquire Barr Pharmaceuticals

Under the terms of the agreement, Teva will acquire 100% of the shares of Barr for total cash and stock consideration of $7.46 billion. Each share of Barr’s